Search results for: France
Filter search results
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
…of 29 drug/indication pairs and a group of 15 countries were studied (Australia, Canada, Denmark, France, Italy, Korea, Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia, Ecuador, Egypt and Ghana). The…
OHE at HTAi Oslo: A New Drug Development Paradigm, a Framework for Developing Formularies in MICs, and the Effect of NICE Decisions Abroad
15 June 2015
…Denmark, France, Italy, Korea, Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia, Ecuador, Egypt and Ghana). Information regarding NICE HTA recommendations was extracted from NICE’s website and HTAinSite.com, and additional information…
Recently Published: New Report Comparing Usage of Medicines in the UK with Other Countries
6 January 2015
…of medicines in the UK relative to 12 comparable high-income countries including France, Germany, Italy, Spain and the USA. Sixteen classes of medicines were included in the original Richards report…
Biosimilar Competition: Lessons from Europe and Prospects for the US
2 December 2014
…granulocyte-colony-stimulating-factors (G-CSFs) has evolved since 2009 in France, Germany, Italy, Sweden and the UK. The author highlights two key results. Firstly, the market experience varies greatly across product classes…
Spotlight on OHE: Adaptive Pathways, Economic Evaluation, Stated Preferences and Life-cycle Price Modelling
5 November 2014
…to look closely at models of health economic evaluation in France, Germany and the UK. This presentation can be watched here http://www.youtube.com/watch?v=AyoScR9BjuU, from 00:29:27 to 1:28:00. Antibiotics and the…
New Report Published: Improving Efficiency and Resource Allocation in Future Cancer Care
26 September 2016
…countries (Belgium, Denmark, France, Germany, Italy, the Netherlands, Poland, Sweden, and the UK) as well as the EU27 average. The report highlights that cancer represents a significant disease burden in…
OHE at ISPOR Europe 1: Impact of NICE on Innovation and Value
22 October 2014
…publicly available sources and an online survey. The countries included are Australia, Canada, Denmark, France, Italy, Korea, The Netherlands, New Zealand, Poland, Portugal, Spain, Bosnia-Herzegovina, Ecuador, Egypt and Ghana. (PHP86,…
ISPOR Task Force Report on Performance-Based Risk-Sharing Arrangements
28 August 2013
…Andrew Briggs, University of Glasgow; Gerard de Pouvourville, ESSEC Business School, France; Jens Grueger, F. Hoffmann-La Roche; Penny Mohr, Center for Medical Technology Policy, USA; J.L. Severens, Erasmus University Rotterdam;…
Exploring the Link Between Health and Wealth in Government Decision Making
16 May 2013
…decision makers in three types of government agencies—finance, health, and HTA—in eight countries: Australia, France, Germany, Italy, Poland, South Korea, Sweden and the UK. We found that only in Sweden…